{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:35:49Z","timestamp":1787070949760,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p>Erythroblastosis fetalis is one of the leading causes of death among newborns and fetuses in India. This condition is characterized by maternal immunoglobin G antibodies destroying the red blood cells (RBCs) of the neonate or fetus, resulting in potentially life-threatening consequences. When a mother with an Rh-positive blood group has a fetus with an Rh-negative blood group, the fetal RBCs trigger maternal antibodies against Rh-antigens. Anti-D antibodies are activated as a result of this process, which is known as isoimmunization. As a result of the antibody reaction, all of the erythrocytes are destroyed, resulting in hemolysis, bilirubin release, and anemia. Intravascular transfusions and intraperitoneal transfusions are examples of antenatal therapies that potentially avoid dangers to the fetus in the early stages of pregnancy. Phototherapy, exchange top-up transfusions, and intravenous immunoglobulin (IVIG) injections are examples of postnatal therapies (IVIG). IVIG therapy is highly recommended since it has a low risk of adverse medication responses and a wide range of survival rates. To avoid isoimmunization, anti-Rh D therapies are indicated. Noninvasive identification of the fetal human platelet antigen 1 genotype using cell-free fetal DNA obtained from maternal blood is one example of progress. This is still in the early stages of research as preventive medicine, the platelet equivalent of Rho (D) Immune Globulin Human (RhoGAM). The erythroblastosis fetalis is highly preventable when it is diagnosed at its early stages. Regular screening of all the patients with ABO incompatibility is necessary to prevent the risks of erythroblastosis fetalis.<\/jats:p>","DOI":"10.4103\/ajts.ajts_50_22","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T04:48:23Z","timestamp":1664254103000},"page":"121-124","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["An overview of recent advances in the prevention of erythroblastosis fetalis"],"prefix":"10.4103","volume":"19","author":[{"given":"Aishwarya","family":"Balasubramaniam","sequence":"first","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical Sciences, Vels Institute of Science Technology and Advanced Studies, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Santhosh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical Sciences, Vels Institute of Science Technology and Advanced Studies, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Priya","sequence":"additional","affiliation":[{"name":"Department of Safety Operations, IQVIA Private Limited, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,9,28]]},"reference":[{"key":"R2-20260422","doi-asserted-by":"crossref","first-page":"64","DOI":"10.21307\/immunohematology-2021-009","article-title":"Statistical model for prediction of ABO hemolytic disease of the Fetus and Newborn in India","volume":"37","author":"Patale","year":"2021","journal-title":"Immunohematology"},{"key":"R4-20260422","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4103\/0019-5049.144645","article-title":"Blood groups systems","volume":"58","author":"Mitra","year":"2014","journal-title":"Indian J Anaesth"},{"key":"R5-20260422","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2147\/PHMT.S327032","article-title":"Hemolytic disease of the newborn: A review of current trends and prospects","volume":"12","author":"Myle","year":"2021","journal-title":"Pediatric Health Med Ther"},{"key":"R6-20260422","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood.V4.11.1249.1249","article-title":"The pathogenesis of erythroblastosis fetalis","volume":"4","author":"Kline","year":"1949","journal-title":"Blood"},{"key":"R7-20260422","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5005\/jp-journals-10065-0023","article-title":"Immune hemolytic disease of the newborn","volume":"2","author":"Saxena","year":"2018","journal-title":"World J Anemia"},{"key":"R8-20260422","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jpedsurg.2014.10.027","article-title":"The many faces of hydrops","volume":"50","author":"Derderian","year":"2015","journal-title":"J Pediatr Surg"},{"key":"R9-20260422","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/sj.jp.7211157","article-title":"Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND)","volume":"25","author":"Shapiro","year":"2005","journal-title":"J Perinatol"},{"issue":"Suppl 1","key":"R10-20260422","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1038\/jp.2008.211","article-title":"Clinical report from the pilot USA Kernicterus Registry (1992 to 2004)","volume":"29","author":"Johnson","year":"2009","journal-title":"J Perinatol"},{"key":"R11-20260422","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/vox.12265","article-title":"Haemolytic disease of the fetus and newborn","volume":"109","author":"de Haas","year":"2015","journal-title":"Vox Sang"},{"key":"R12-20260422","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ajog.2004.06.063","article-title":"Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization","volume":"192","author":"Van Kamp","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R13-20260422","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/01.AOG.0000284623.15170.0d","article-title":"Intraperitoneal transfusion in severe, early-onset Rh isoimmunization","volume":"110","author":"Howe","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R14-20260422","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0002-9378(88)90094-4","article-title":"The reversal of hydrops fetalis by intravascular intrauterine transfusions in severe is immune fetal anemia","volume":"158","author":"Grannum","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"R15-20260422","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/17474086.2017.1331124","article-title":"Neonatal management and outcome in alloimmune hemolytic disease","volume":"10","author":"Ree","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"R16-20260422","doi-asserted-by":"crossref","first-page":"4.e1","DOI":"10.1016\/j.ajog.2007.05.030","article-title":"Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion","volume":"198","author":"De Boer","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R17-20260422","first-page":"207","article-title":"Therapy of erythroblastosis fetalis with exchange transfusion","volume":"23","author":"Wiener","year":"1947","journal-title":"Bull N Y Acad Med"},{"key":"R19-20260422","doi-asserted-by":"crossref","first-page":"503","DOI":"10.32677\/IJCH.2019.v06.i09.009","article-title":"Exchange transfusion in neonates: An experience from a tertiary care center in north India","volume":"06","author":"Naranje","year":"2019","journal-title":"Indian J Child Health (Bhopal)"},{"key":"R20-20260422","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1159\/000490154","article-title":"Efficacy of antenatal intravenous immunoglobulin treatment in pregnancies at high risk due to alloimmunization to red blood cells","volume":"45","author":"Mayer","year":"2018","journal-title":"Transfus Med Hemother"},{"key":"R21-20260422","doi-asserted-by":"crossref","first-page":"F6","DOI":"10.1136\/fn.88.1.F6","article-title":"Systematic review of intravenous immunoglobulin in hemolytic disease of the newborn","volume":"88","author":"Gottstein","year":"2003","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R22-20260422","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1542\/peds.114.1.297","article-title":"Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation","volume":"114","year":"2004","journal-title":"Pediatrics"},{"key":"R24-20260422","doi-asserted-by":"crossref","first-page":"E57","DOI":"10.1097\/AOG.0000000000002232","article-title":"Practice bulletin no. 181: Prevention of Rh D alloimmunization","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R25-20260422","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ajog.2021.04.211","article-title":"New developments in fetal and neonatal alloimmune thrombocytopenia","volume":"225","author":"Bussel","year":"2021","journal-title":"Am J Obstet Gynecol"}],"container-title":["Asian Journal of Transfusion Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_50_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:39:27Z","timestamp":1787067567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_50_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ajts.ajts_50_22","relation":{},"ISSN":["0973-6247","1998-3565"],"issn-type":[{"value":"0973-6247","type":"print"},{"value":"1998-3565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,28]]},"assertion":[{"value":"2022-04-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}